These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2194737)
21. Promoting rational drug use through the ASHP Commission on Therapeutics. Witmer DR Am J Hosp Pharm; 1994 Jun; 51(12):1536. PubMed ID: 8092154 [No Abstract] [Full Text] [Related]
22. New options for spontaneous bacterial prophylaxis: costly or cost effective? Levy MJ; DiPalma JA Am J Gastroenterol; 1996 May; 91(5):1050-1. PubMed ID: 8633556 [No Abstract] [Full Text] [Related]
23. Bacterial infections transmitted from the donor: antibiotic prophylaxis in the donor. Pacholczyk MJ; Lagiewska B; Mészáros J; Szostek M; Rowiński W Transplant Proc; 1996 Feb; 28(1):184-5. PubMed ID: 8644169 [No Abstract] [Full Text] [Related]
24. Transplant infectious disease: a work in progress. Rubin RH Transpl Infect Dis; 2005 Jun; 7(2):49-50. PubMed ID: 16150089 [No Abstract] [Full Text] [Related]
25. The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy. Marty FM; Rubin RH Transpl Int; 2006 Jan; 19(1):2-11. PubMed ID: 16359371 [TBL] [Abstract][Full Text] [Related]
27. Use of antimicrobial-impregnated polymethyl methacrylate. Tobias KM; Schneider RK; Besser TE J Am Vet Med Assoc; 1996 Mar; 208(6):841-5. PubMed ID: 8617638 [No Abstract] [Full Text] [Related]
28. [Efficacy and clinical value of hemocultures during antimicrobial treatment in patients with neutropenia]. Salerno RA Medicina (B Aires); 1986; 46(6):761-2. PubMed ID: 3626845 [No Abstract] [Full Text] [Related]
30. The therapeutic prescription for the patient undergoing immunosuppressing therapy. Rubin RH Online J Curr Clin Trials; 1993 Sep; Doc No 86():[969 words; 7 paragraphs]. PubMed ID: 8306014 [No Abstract] [Full Text] [Related]
31. Editorial: The ASHP council on clinical pharmacy and therapeutics. Zellmer WA Am J Hosp Pharm; 1974 Sep; 31(9):831. PubMed ID: 4423139 [No Abstract] [Full Text] [Related]
32. ASHP statement on the pharmacist's role in infection control. Am J Health Syst Pharm; 1998 Aug; 55(16):1724-6. PubMed ID: 9740912 [No Abstract] [Full Text] [Related]
33. [The antimicrobial treatment of digestive diseases]. Sánchez Ruiz F An Esp Pediatr; 1989 Sep; 31 Suppl 38():86-93. PubMed ID: 2490632 [No Abstract] [Full Text] [Related]
34. Antimicrobial use principles drafted; steering committee invites comments. J Am Vet Med Assoc; 1998 Sep; 213(6):763, 779. PubMed ID: 9743707 [No Abstract] [Full Text] [Related]
35. ASHP statement on the pharmacy and therapeutics committee. Am J Hosp Pharm; 1986 Nov; 43(11):2841-2. PubMed ID: 3799625 [No Abstract] [Full Text] [Related]
36. [Antimicrobial prophylaxis in urological surgery]. Antelava NA; Pirtskhalaĭshvili NN; Antelava AV; Pachkoriia KZ Georgian Med News; 2007 Jun; (147):63-71. PubMed ID: 17660605 [TBL] [Abstract][Full Text] [Related]
37. Current status of topical nasal antimicrobial agents. Goh YH; Goode RL Laryngoscope; 2000 Jun; 110(6):875-80. PubMed ID: 10852500 [TBL] [Abstract][Full Text] [Related]
38. ASHP statement on the pharmacy and therapeutics committee. Am J Hosp Pharm; 1978 Jul; 35(7):813-4. PubMed ID: 665701 [No Abstract] [Full Text] [Related]
39. [Current methods of anti-infectious prophylaxis in patients with HIV infection]. Mayaud C; Parrot A; Cadranel J Rev Mal Respir; 1994; 11(4):433-5. PubMed ID: 7973047 [No Abstract] [Full Text] [Related]
40. [Co-trimoxazole chemoprophylaxis in immunocompromised patients: analysis of the literature]. Gava R; Carli M G Clin Med; 1989 Jan; 70(1):37-9, 42-6. PubMed ID: 2668092 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]